A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 4,566,817 shares of XLO stock, worth $4.29 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
4,566,817
Previous 3,785,450 20.64%
Holding current value
$4.29 Million
Previous $3.6 Million 0.31%
% of portfolio
0.65%
Previous 0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.73 - $1.02 $570,397 - $796,994
781,367 Added 20.64%
4,566,817 $3.61 Million
Q2 2024

Aug 12, 2024

BUY
$0.9 - $1.53 $882,033 - $1.5 Million
980,037 Added 34.93%
3,785,450 $3.6 Million
Q4 2021

Feb 14, 2022

BUY
$9.69 - $25.11 $27.2 Million - $70.4 Million
2,805,413 New
2,805,413 $44.9 Million

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $25.8M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.